Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...

Cipla has received final US FDA approval for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia ...

Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...

>> Long build up is seen in CIPLA Futures, where we have seen 4 per cent rise in the open interest on the day when Cipla ...

So, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the ...

Welcome to the Cipla Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent ...

HYDERABAD/BENGALURU, Jan 28 (Reuters) - Cipla (CIPL.NS), opens new tab, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by strong ...

Cipla share price will remain in focus after the United States Food and Drug Administration (USFDA) has classified the ...

The Indian market is expected to consolidate on Wednesday, influenced by muted global cues. The Nifty futures closed slightly ...

The USFDA has conducted routine cGMP inspection at the facility in the period between November 7 through November 13, 2024.

Cipla share price today: The pharma major reported a 49% increase in net profit, reaching Rs 1,571 crore (Image: Reuters) Motilal Oswal has maintained a Neutral rating on Cipla, with a target ...